UBS Group’s LAVA Therapeutics LVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$21.6K Sell
2025
Q1
$21.5K Sell
2024
Q4
$17.5K Buy
2024
Q3
$1.78K Buy
2024
Q2
Sell
2024
Q1
$29.9K Buy
2023
Q2
Sell
2023
Q1
$6.8K Buy
2022
Q4
$3.5K Buy
2022
Q3
Sell
2022
Q2
$1K Sell
2022
Q1
$5K Sell
2021
Q4
$10K Buy